Skip to content

Clinical trials

Completed Fabry Disease trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fabry Disease Status: Completed Country / region: United States Clear all

56 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20013
20023
20034
20044
20051
20062
20071
20082
20092
20103
20115
20123
20142
20152
20163
20171
20184
20192
20202
20221
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed56

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amicus Therapeutics12
National Institute of Neurological Disorders and Stroke (NINDS)11
Genzyme, a Sanofi Company8
Shire5
Protalix4
Baylor Research Institute3
Chiesi Farmaceutici S.p.A.3
Massachusetts General Hospital2
University of Alabama at Birmingham2
Idorsia Pharmaceuticals Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fabry Disease56
Stroke9
Proteinuria6
Hypohidrosis3
Lysosomal Storage Diseases3
Peripheral Nervous System Diseases2
Alopecia1
Angiokeratoma1
Ehlers-Danlos Syndrome1
Heart Diseases1

Trials

Showing 1 to 25 of 56. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.